NCAPH2

non-SMC condensin II complex subunit H2, the group of Condensin II subunits

Basic information

Region (hg38): 22:50508224-50524780

Links

ENSG00000025770NCBI:29781OMIM:611230HGNC:25071Uniprot:Q6IBW4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NCAPH2 gene.

  • not provided (21 variants)
  • Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 (5 variants)
  • Myopia 6 (2 variants)
  • Seizure;Severe global developmental delay (1 variants)
  • Tip-toe gait (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NCAPH2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
41
clinvar
3
clinvar
1
clinvar
45
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
22
clinvar
20
clinvar
150
clinvar
140
clinvar
5
clinvar
337
Total 22 20 191 143 8

Highest pathogenic variant AF is 0.000105

Variants in NCAPH2

This is a list of pathogenic ClinVar variants found in the NCAPH2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
22-50516456-A-G not specified Uncertain significance (May 24, 2024)3298741
22-50516499-T-C not specified Uncertain significance (Nov 12, 2021)2347561
22-50517635-G-A not specified Likely benign (Oct 12, 2022)2344415
22-50517642-C-T not specified Uncertain significance (Dec 01, 2022)2330294
22-50517802-C-T not specified Uncertain significance (Dec 15, 2023)3181668
22-50517805-C-T not specified Uncertain significance (Sep 27, 2021)2252365
22-50517991-C-T not specified Uncertain significance (Feb 22, 2023)3181672
22-50518031-A-G not specified Uncertain significance (Aug 30, 2021)2247365
22-50518180-C-T not specified Uncertain significance (Mar 25, 2024)3298740
22-50518194-C-G not specified Uncertain significance (Sep 16, 2021)2249935
22-50518218-C-T not specified Uncertain significance (Jan 20, 2023)2476918
22-50518248-G-C not specified Uncertain significance (Aug 19, 2023)2619490
22-50518654-G-A not specified Likely benign (Aug 21, 2023)2596500
22-50518675-A-G not specified Uncertain significance (Sep 06, 2022)3181691
22-50518686-C-T Benign (Mar 29, 2018)775456
22-50518687-G-A not specified Uncertain significance (Oct 26, 2022)2208019
22-50518703-T-C not specified Uncertain significance (Mar 25, 2024)3298739
22-50518731-A-G Likely benign (Aug 01, 2022)2653398
22-50519196-C-T not specified Uncertain significance (Oct 06, 2021)2388179
22-50519210-A-C not specified Uncertain significance (Dec 14, 2023)3181702
22-50519225-G-A not specified Uncertain significance (Feb 06, 2023)2480960
22-50519285-G-A not specified Likely benign (Feb 12, 2024)3181708
22-50520996-G-A not specified Uncertain significance (Aug 12, 2022)2207821
22-50521007-G-C not specified Uncertain significance (Nov 15, 2021)2261448
22-50521022-G-A not specified Uncertain significance (Dec 15, 2022)2335167

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NCAPH2protein_codingprotein_codingENST00000299821 2015257
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0002881.001257160321257480.000127
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1763463550.9740.00002143945
Missense in Polyphen101124.30.812551510
Synonymous-2.661891481.280.000009641159
Loss of Function3.661337.10.3510.00000175415

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005790.0000579
Ashkenazi Jewish0.000.00
East Asian0.0001110.000109
Finnish0.0002430.000231
European (Non-Finnish)0.0001810.000167
Middle Eastern0.0001110.000109
South Asian0.0001320.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulatory subunit of the condensin-2 complex, a complex that seems to provide chromosomes with an additional level of organization and rigidity and in establishing mitotic chromosome architecture. May play a role in lineage-specific role in T-cell development (By similarity). {ECO:0000250, ECO:0000269|PubMed:14532007}.;
Pathway
Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle;Cell Cycle, Mitotic (Consensus)

Recessive Scores

pRec
0.0969

Intolerance Scores

loftool
0.0236
rvis_EVS
-0.22
rvis_percentile_EVS
37.66

Haploinsufficiency Scores

pHI
0.122
hipred
N
hipred_score
0.456
ghis
0.596

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.631

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ncaph2
Phenotype
immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
meiotic chromosome condensation;T cell differentiation in thymus;chromosome organization;mitotic sister chromatid separation;female meiosis chromosome separation
Cellular component
condensed chromosome;condensin complex;nucleus;nucleoplasm;membrane;cell junction;intercellular bridge
Molecular function
chromatin binding;protein binding